Skip to content

Clinical trials

Completed Blastic Plasmacytoid Dendritic Cell Neoplasm trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm Status: Completed Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20111
20131
20141
20152
20162
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
City of Hope Medical Center1
Dana-Farber Cancer Institute1
M.D. Anderson Cancer Center1
Mayo Clinic1
National Cancer Institute (NCI)1
Stemline Therapeutics, Inc.1
University of Texas Southwestern Medical Center1
Xencor, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blastic Plasmacytoid Dendritic Cell Neoplasm10
Leukemia, Myeloid, Acute7
Burkitt Lymphoma5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Blast Crisis3
Leukemia, Biphenotypic, Acute3
Leukemia, Hairy Cell3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Lymphoma, B-Cell, Marginal Zone3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.